| Pain Management |
1 |
0.48 |
| Tumor |
0 |
0.77 |
| Neurofibromatosis Type 1 |
0 |
0.6 |
| Acute Pain |
0 |
0.45 |
| Revenue and Practice Management |
0 |
0.36 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.3 |
| HIV Infection |
0 |
0.3 |
| Child |
0 |
0.29 |
| Patient Safety |
0 |
0.27 |
| Neurofibromatosis |
0 |
0.24 |
| Laser |
0 |
0.18 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.18 |
| Hospital |
0 |
0.12 |
| Massachusetts |
0 |
0.12 |
| Social Determinants of Health |
0 |
0.1 |
| General Anesthesia |
0 |
0.08 |
| Health Insurance |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Anesthesia |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Cryotherapy |
0 |
0.06 |
| Health Care Quality, Access, and Evaluation |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Nodule |
0 |
0.06 |
| Orbit |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Three-Dimensional Imaging |
0 |
0.06 |